厄贝沙坦联合丹参酮ⅡA治疗糖尿病肾病临床疗效观察

被引:2
作者
黄彦思
机构
[1] 广东省东莞企石医院
关键词
糖尿病肾病; 厄贝沙坦; 丹参酮ⅡA;
D O I
暂无
中图分类号
R587.2 [糖尿病性昏迷及其他并发症];
学科分类号
100201 [内科学];
摘要
目的:观察厄贝沙坦联合丹参酮ⅡA治疗糖尿病肾病的临床疗效。方法:将70例糖尿病肾病患者分为对照组和治疗组,两组均使用胰岛素和口服降糖药,严格控制血糖和血压在正常范围,对照组单纯使用厄贝沙坦,治疗组在此基础上给予丹参酮ⅡA,观察期间检测患者尿蛋白排泄率(UAER)、空腹血糖、肾功能及血脂,比较两组尿微量白蛋白排泄率和血液高凝状态。结果:治疗组疗效明显优于对照组(P<0.05)。结论:厄贝沙坦联合丹参酮ⅡA对糖尿病肾病效果明显,值得临床推广应用。
引用
收藏
页码:41 / 42
页数:2
相关论文
共 3 条
[1]
关于糖尿病新诊断标准与分型的意义 [J].
钱荣立 .
临床内科杂志, 2000, (03) :133
[2]
Effects of Atorvastatin on Kidney Outcomes and Cardiovascular Disease in Patients With Diabetes: An Analysis From the Collaborative Atorvastatin Diabetes Study (CARDS) [J].
Colhoun, Helen M. ;
Betteridge, D. John ;
Durrington, Paul N. ;
Hitman, Graham A. ;
Neil, H. Andrew W. ;
Livingstone, Shona J. ;
Charlton-Menys, Valentine ;
DeMicco, David A. ;
Fuller, John H. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 54 (05) :810-819
[3]
A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance [J].
Sasaki, Jun ;
Ikeda, Yoshihiko ;
Kuribayashi, Tadanobu ;
Kajiwara, Keizou ;
Biro, Sadatoshi ;
Yamamoto, Kyosuke ;
Ageta, Masato ;
Kobori, Syozou ;
Saikawa, Tetsunori ;
Otonari, Takatoshi ;
Kono, Suminori .
CLINICAL THERAPEUTICS, 2008, 30 (06) :1089-1101